|
1
|
Rogers PA, D'Hooghe TM, Fazleabas A, et
al: Priorities for endometriosis research: recommendations from an
international consensus workshop. Reprod Sci. 16:335–346. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gemmill JA, Stratton P, Cleary SD, Ballweg
ML and Sinaii N: Cancers, infections, and endocrine diseases in
women with endometriosis. Fertil Steril. 94:1627–1631. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Jefout M, Tokushige N, Hey-Cunningham
AJ, et al: Microanatomy and function of the eutopic endometrium in
endometriosis. Expert Rev Obstet Gynecol. 4:61–79. 2009. View Article : Google Scholar
|
|
4
|
Brinton LA, Gridley G, Persson I, Baron J
and Bergqvist A: Cancer risk after a hospital discharge diagnosis
of endometriosis. Am J Obstet Gynecol. 176:572–579. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brinton LA, Lamb EJ, Moghissi KS, et al:
Ovarian cancer risk associated with varying causes of infertility.
Fertil Steril. 82:405–414. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kokcu A: Relationship between
endometriosis and cancer from current perspective. Arch Gynecol
Obstet. 284:1473–1479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nezhat F, Datta MS, Hanson V, Pejovic T
and Nezhat C and Nezhat C: The relationship of endometriosis and
ovarian malignancy: a review. Fertil Steril. 90:1559–15570. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grammatikakis I, Zervoudis S,
Evangelinakis N and Tziortzioti V: Endometrium and ovarian cancer
synchronous to endometriosis - a retrospective study of our
experience of 7 years. J Med Life. 3:76–79. 2010.PubMed/NCBI
|
|
9
|
Stern RC, Dash R, Bentley RC, Snyder MJ,
Haney AF and Robboy SJ: Malignancy in endometriosis: frequency and
comparison of ovarian and extraovarian types. Int J Gynecol Pathol.
20:133–139. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mabrouk M, Vicenzi C, Ferrini G, et al:
Mixed adenocarcinoma of the rectovaginal septum associated with
endometriosis and endometrial carcinoma: a case report. Case Rep
Oncol. 4:149–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Veiga-Castelli LC, Silva JC, Meola J, et
al: Genomic alterations detected by comparative genomic
hybridization in ovarian endometriomas. Braz J Med Biol Res.
43:799–805. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wiegand KC, Shah SP, Al-Agha OM, et al:
ARID1A mutations in endometriosis-associated ovarian carcinomas. N
Engl J Med. 363:1532–1543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamamoto S, Tsuda H, Takano M, Iwaya K,
Tamai S and Matsubara O: PIK3CA mutation is an early event in the
development of endometriosis-associated ovarian clear cell
adenocarcinoma. J Pathol. 225:189–194. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scott RB: Malignant changes in
endometriosis. Obstet Gynecol. 2:283–289. 1953.
|
|
15
|
Scully RE, Richardson GS and Barlow JF:
The development of malignancy in endometriosis. Clin Obstet
Gynecol. 9:384–411. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Omranipour R and Najafi M: Papillary
serous carcinoma arising in abdominal wall endometriosis treated
with neoadjuvant chemotherapy and surgery. Fertil Steril.
93:1347.e17–e18. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heaps JM, Nieberg RK and Berek JS:
Malignant neoplasms arising in endometriosis. Obstet Gynecol.
75:1023–1028. 1990.PubMed/NCBI
|
|
18
|
Sayasneh A, Tsivos D and Crawford R:
Endometriosis and ovarian cancer: a systematic review. ISRN Obstet
Gynecol. 2011:1403102011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kobayashi H, Sumimoto K, Moniwa N, et al:
Risk of developing ovarian cancer among women with ovarian
endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol
Cancer. 17:37–43. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takeuchi M, Matsuzaki K, Uehara H and
Nishitani H: Malignant transformation of pelvic endometriosis: MR
imaging findings and pathologic correlation. Radiographics.
26:407–417. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McCluggage WG, Bryson C, Lamki H and Boyle
DD: Benign, borderline, and malignant endometrioid neoplasia
arising in endometriosis in association with tamoxifen therapy. Int
J Gynecol Pathol. 19:276–279. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martin DC: Cancer and endometriosis: do we
need to be concerned? Semin Reprod Endocrinol. 15:319–324. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho KR and Shih IeM: Ovarian cancer. Annu
Rev Pathol. 4:287–313. 2009. View Article : Google Scholar
|
|
24
|
Jones S, Wang TL, Shih IeM, et al:
Frequent mutations of chromatin remodeling gene ARID1A in ovarian
clear cell carcinoma. Science. 330:228–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guan B, Wang TL and Shih IM: ARID1A, a
factor that promotes formation of SWI/SNF-mediated chromatin
remodeling, is a tumor suppressor in gynecologic cancers. Cancer
Res. 71:6718–6727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao C, Wu LS and Barner R: Pathogenesis
of ovarian clear cell adenofibroma, atypical proliferative
(borderline) tumor, and carcinoma: clinicopathologic features of
tumors with endometriosis or adenofibromatous components support
two related pathways of tumor development. J Cancer. 2:94–106.
2011. View
Article : Google Scholar
|
|
27
|
Mandai M, Matsumura N, Baba T, Yamaguchi
K, Hamanishi J and Konishi I: Ovarian clear cell carcinoma as a
stress-responsive cancer: influence of the microenvironment on the
carcinogenesis and cancer phenotype. Cancer Lett. 310:129–133.
2011. View Article : Google Scholar
|
|
28
|
Yamaguchi K, Mandai M, Toyokuni S, et al:
Contents of endometriotic cysts, especially the high concentration
of free iron, are a possible cause of carcinogenesis in the cysts
through the iron-induced persistent oxidative stress. Clin Cancer
Res. 4:32–40. 2008. View Article : Google Scholar
|
|
29
|
Kobayashi H, Kajiwara H, Kanayama S, et
al: Molecular pathogenesis of endometriosis-associated clear cell
carcinoma of the ovary (Review). Oncol Rep. 22:233–240.
2009.PubMed/NCBI
|
|
30
|
Kuo KT, Mao TL, Jones S, et al: Frequent
activating mutations of PIK3CA in ovarian clear cell carcinoma. Am
J Pathol. 174:1597–1601. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamamoto S, Tsuda H, Takano M, et al:
Expression of platelet-derived growth factors and their receptors
in ovarian clear-cell carcinoma and its putative precursors. Mod
Pathol. 21:115–124. 2008.PubMed/NCBI
|
|
32
|
Kobayashi H, Yamada Y, Kanayama S, et al:
The role of hepatocyte nuclear factor-1β in the pathogenesis of
clear cell carcinoma of the ovary. Int J Gynecol Cancer.
19:471–479. 2009.
|
|
33
|
Fukunaga M, Nomura K, Ishikawa E and
Ushigome S: Ovarian atypical endometriosis: its close association
with malignant epithelial tumours. Histopathology. 30:249–255.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Srinivasan R, Gupta N and Gupta I:
Recurrent endocervical-like mucinous borderline tumor (ELMBT)
arising in a case of long-standing endometriosis - a case report.
Indian J Pathol Microbiol. 49:277–278. 2006.PubMed/NCBI
|
|
35
|
Biscotti CV and Hart WR: Peritoneal serous
micropapillomatosis of low malignant potential (serous borderline
tumors of the peritoneum). A clinicopathologic study of 17 cases.
Am J Surg Pathol. 16:467–745. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tinelli A, Malvasi A and Pellegrino M: An
incidental peritoneal serous borderline tumor during laparoscopy
for endometriosis. Eur J Gynaecol Oncol. 30:579–582.
2009.PubMed/NCBI
|
|
37
|
Carlson J, Roh MH, Chang MC and Crum CP:
Recent advances in the understanding of the pathogenesis of serous
carcinoma: the concept of low- and high-grade disease and the role
of the fallopian tube. Diagn Histopathol (Oxford). 14:352–365.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McCoubrey A, Houghton O, McCallion K and
McCluggage WG: Serous adenocarcinoma of the sigmoid mesentery
arising in cystic endosalpingiosis. J Clin Pathol. 58:1221–1223.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cil AP, Atasoy P and Kara SA: Myometrial
involvement of tumor-like cystic endosalpingiosis: a rare entity.
Ultrasound Obstet Gynecol. 32:106–110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kurman RJ and Shih IeM: The origin and
pathogenesis of epithelial ovarian cancer: a proposed unifying
theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mayr D, Hirschmann A, Löhrs U and Diebold
J: KRAS and BRAF mutations in ovarian tumors: a comprehensive study
of invasive carcinomas, borderline tumors and extraovarian
implants. Gynecol Oncol. 103:883–887. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hamada T, Kiyokawa T, Nomura K and Hano H:
Immunohistochemical analysis of reserve cell-like cells of ovarian
müllerian mucinous/mixed epithelial borderline tumor. Int J Gynecol
Pathol. 27:199–206. 2008.PubMed/NCBI
|
|
43
|
Moriya T, Mikami Y, Sakamoto K, et al:
Endocervical-like mucinous borderline tumors of the ovary:
clinicopathological features and electron microscopic findings. Med
Electron Microsc. 36:240–246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee KR and Nucci MR: Ovarian mucinous and
mixed epithelial carcinomas of mullerian (endocervical-like) type:
a clinicopathologic analysis of four cases of an uncommon variant
associated with endometriosis. Int J Gynecol Pathol. 22:42–51.
2003. View Article : Google Scholar
|
|
45
|
D'Angelo E, Dadmanesh F, Pecorelli S and
Prat J: Squamous cell carcinoma of the ovary arising from a
mucinous cystic tumor of endocervical (müllerian) type. Int J
Gynecol Pathol. 29:529–532. 2010.PubMed/NCBI
|
|
46
|
Kim KR, Choi J, Hwang JE, et al:
Endocervical-like (Müllerian) mucinous borderline tumours of the
ovary are frequently associated with the KRAS mutation.
Histopathology. 57:587–596. 2010.
|
|
47
|
Shin JH, Bae JH, Lee A, et al: CK7, CK20,
CDX2 and MUC2 Immunohistochemical staining used to distinguish
metastatic colorectal carcinoma involving ovary from primary
ovarian mucinous adenocarcinoma. Jpn J Clin Oncol. 40:208–213.
2010. View Article : Google Scholar
|
|
48
|
Auner V, Kriegshäuser G, Tong D, et al:
KRAS mutation analysis in ovarian samples using a high sensitivity
biochip assay. BMC Cancer. 9:1112009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Patrelli TS, Gizzo S, Di Gangi S, Guidi G,
Rondinelli M and Nardelli GB: Cervical Mullerian adenosarcoma with
heterologous sarcomatous overgrowth: a fourth case and review of
literature. BMC Cancer. 11:2362011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
McCluggage WG: Mullerian adenosarcoma of
the female genital tract. Adv Anat Pathol. 17:122–129. 2010.
View Article : Google Scholar
|
|
51
|
Han X, Leng J, Guo L, Xiang Y and Lang J:
Vaginal adenosarcoma arising from refractory endometriosis: a case
report. Aust N Z J Obstet Gynaecol. 50:574–576. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Patrelli TS, Silini EM, Gizzo S, et al:
Extragenital Müllerian adenosarcoma with pouch of Douglas location.
BMC Cancer. 11:1712011.
|
|
53
|
Singh R, Shameema S, Vijaya K and Kumar P:
Mullerian adenosarcoma of the uterus with sarcomatous overgrowth.
Clin Med Insights Case Rep. 3:27–30. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chung YW, Bae HS, Han SI, Song JY, Kim IS
and Kang JS: Endometrial mullerian adenosarcoma after toremifene
treatment in breast cancer patients: a case report. J Gynecol
Oncol. 21:269–272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yasuoka H, Tsujimoto M, Fujita S, et al:
Coexistence of a clear cell adenocarcinoma and an adenosarcoma with
a heterologous rhabdomyosarcoma in an endometriotic cyst of the
ovary: a case study. Int J Gynecol Pathol. 28:362–366. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Clement PB and Scully RE: Mullerian
adenosarcoma of the uterus. A clinicopathologic analysis of ten
cases of a distinctive type of mullerian mixed tumor. Cancer.
34:1138–1149. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gallardo A and Prat J: Mullerian
adenosarcoma: a clinicopathologic and immunohistochemical study of
55 cases challenging the existence of adenofibroma. Am J Surg
Pathol. 33:278–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hrzenjak A, Moinfar F, Tavassoli FA, et
al: JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas:
molecular analysis by reverse transcriptase-polymerase chain
reaction optimized for paraffin-embedded tissue. J Mol Diagn.
7:388–395. 2005. View Article : Google Scholar
|
|
59
|
Jung SI, Shin SS, Choi C, Hwang EC, Kim SO
and Kang TW: Endometrial stromal sarcoma presenting as prevesical
mass mimicking urachal tumor. J Korean Med Sci. 24:529–531. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Froio E, Piana S, Cavazza A, Valli R,
Abrate M and Gardini G: Multifocal PEComa (PEComatosis) of the
female genital tract associated with endometriosis, diffuse
adenomyosis, and endometrial atypical hyperplasia. Int J Surg
Pathol. 16:443–446. 2008. View Article : Google Scholar
|
|
61
|
Kim JY, Hong SY, Sung HJ, Oh HK and Koh
SB: A case of multiple metastatic low-grade endometrial stromal
sarcoma arising from an ovarian endometriotic lesion. J Gynecol
Oncol. 20:122–125. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Khan AW, Craig M, Jarmulowicz M and
Davidson BR: Liver tumours due to endometriosis and endometrial
stromal sarcoma. HPB (Oxford). 4:43–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Baiocchi G, Kavanagh JJ and Wharton JT:
Endometrioid stromal sarcomas arising from ovarian and extraovarian
endometriosis: report of two cases and review of the literature.
Gynecol Oncol. 36:147–151. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Roşca E, Venter A, Muţiu G, Drăgan A,
Coroi M and Roşca DM: Endometrial stromal sarcoma developed on
outer endometriosis foci. Rom J Morphol Embryol. 52:489–492.
2011.PubMed/NCBI
|
|
65
|
Chiang S and Oliva E: Cytogenetic and
molecular aberrations in endometrial stromal tumors. Hum Pathol.
42:609–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cheng CW, Smith SK and Charnock-Jones DS:
Transcript profile and localization of Wnt signaling-related
molecules in human endometrium. Fertil Steril. 90:201–204. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Irvin W, Pelkey T, Rice L and Andersen W:
Endometrial stromal sarcoma of the vulva arising in extraovarian
endometriosis: a case report and literature review. Gynecol Oncol.
71:313–316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Viganó P, Somigliana E, Chiodo I, Abbiati
A and Vercellini P: Molecular mechanisms and biological
plausibility underlying the malignant transformation of
endometriosis: a critical analysis. Hum Reprod Update. 12:77–89.
2006.PubMed/NCBI
|
|
69
|
Toyokuni S: Mysterious link between iron
overload and CDKN2A/2B. J Clin Biochem Nutr. 48:46–49. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Toyokuni S: Molecular mechanisms of
oxidative stress-induced carcinogenesis: from epidemiology to
oxygenomics. IUBMB Life. 60:441–447. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kajihara H, Yamada Y, Kanayama S, et al:
Clear cell carcinoma of the ovary: Potential pathogenic mechanisms.
Oncol Rep. 23:1193–1203. 2010.PubMed/NCBI
|
|
72
|
Yamada Y, Shigetomi H, Onogi A, et al:
Redox-active iron-induced oxidative stress in the pathogenesis of
clear cell carcinoma of the ovary. Int J Gynecol Cancer.
21:1200–1207. 2011.PubMed/NCBI
|
|
73
|
Mandai M, Yamaguchi K, Matsumura N, Baba T
and Konishi I: Ovarian cancer in endometriosis: molecular biology,
pathology, and clinical management. Int J Clin Oncol. 14:383–391.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Yamaguchi K, Mandai M, Oura T, et al:
Identification of an ovarian clear cell carcinoma gene signature
that reflects inherent disease biology and the carcinogenic
processes. Oncogene. 29:1741–1752. 2010. View Article : Google Scholar : PubMed/NCBI
|
